🇺🇸 FDA
Patent

US 9428731

Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

granted A61KA61K35/30A61P

Quick answer

US patent 9428731 (Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells) held by San Diego Regenerative Medicine Institute expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
San Diego Regenerative Medicine Institute
Grant date
Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/30, A61P, A61P25/00, A61P25/16